{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:04:03Z","timestamp":1784066643929,"version":"3.55.0"},"reference-count":0,"publisher":"Pasifika Medical Association Group","issue":"1638","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NZMJ"],"abstract":"<jats:p>aims: We aimed to evaluate the diagnostic correlation between intestinal ultrasound (IUS) and follow-up investigations, and to\ndescribe the impact of IUS on clinical decision making, particularly point-of-care use.\nmethods: A retrospective audit of consecutive IUS examinations in Wellington Regional Hospital for inflammatory bowel disease (IBD)\nfrom December 2021 to February 2025 was conducted. Follow-up investigations (faecal calprotectin [FCP], endoscopy, cross-sectional\nimaging or repeat IUS) within 6 months were collated and correlation assessed using two pre-specified composites, using two FCP\nthresholds: a conservative cutoff of &lt;50mcg\/g and a more liberal threshold of &lt;150mcg\/g.1 Additional outcomes included decisionaltering\nimpact and time to decision.\nresults: We analysed 373 IUS examinations in 253 patients (89.5% Crohn\u2019s disease [CD]; 34.6% point-of-care). IUS directly altered\nclinical decisions in 134\/373 (35.9%), with 70\/134 (52.2%) decisions made the same day. Follow-up occurred after 160\/373 scans\n(42.9%). Excluding five \u201cnot commentable\u201d scans, correlation was 141\/155 (91.0%) using FCP &lt;150mcg\/g and 128\/155 (82.6%) using\nFCP &lt;50mcg\/g.\nconclusion: In this real-world New Zealand cohort, IUS correlated strongly with follow-up investigations, particularly using an FCP\n&lt;150mcg\/g threshold, and frequently altered management, often on the same day. These findings support wider implementation of\nIUS as a radiation-sparing, point-of-care monitoring tool in New Zealand.<\/jats:p>","DOI":"10.26635\/6965.7422","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:23:28Z","timestamp":1784064208000},"page":"19-27","source":"Crossref","is-referenced-by-count":0,"title":["Intestinal ultrasound in inflammatory bowel disease: diagnostic accuracy and impact on clinical decision making in a New Zealand tertiary centre"],"prefix":"10.26635","volume":"139","author":[{"given":"Dongyeon","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-yi","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11177","published-online":{"date-parts":[[2026,7,17]]},"container-title":["New Zealand Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:23:29Z","timestamp":1784064209000},"score":1,"resource":{"primary":{"URL":"https:\/\/nzmj.org.nz\/journal\/vol-139-no-1638\/intestinal-ultrasound-in-inflammatory-bowel-disease-diagnostic-accuracy-and-impact-on-clinical-decision-making-in-a-new-zealand-"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":0,"journal-issue":{"issue":"1638","published-online":{"date-parts":[[2026,7,17]]}},"URL":"https:\/\/doi.org\/10.26635\/6965.7422","relation":{},"ISSN":["1175-8716"],"issn-type":[{"value":"1175-8716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}